There are 2949 resources available
1897P - Germline and somatic mutational landscape in a cohort of malignant pleural mesothelioma patients
Presenter: Mireia Gausachs
Session: E-Poster Display
Resources:
Abstract
1898P - A phase II trial of first-line combination chemotherapy with cisplatin, pemetrexed, and nivolumab for unresectable malignant pleural mesothelioma: JME-001
Presenter: Nobukazu Fujimoto
Session: E-Poster Display
Resources:
Abstract
1899P - Autoimmune diseases in centrally reviewed thymic epithelial tumours (TET)
Presenter: Jose Carlos Benitez Montanez
Session: E-Poster Display
Resources:
Abstract
1900P - RAMES trial: A multicentre, double-blind, randomized, phase II study on gemcitabine plus ramucirumab versus gemcitabine alone as second-line treatment for advanced malignant pleural mesothelioma (MPM)
Presenter: Maria Pagano
Session: E-Poster Display
Resources:
Abstract
1901P - Immunomodulatory role of multi-agent therapy in thymic epithelial tumours and severe immunological dysregulation
Presenter: Margaret Ottaviano
Session: E-Poster Display
Resources:
Abstract
1902P - Association of high-intensity statins with clinical outcome in malignant pleural mesothelioma and advanced non-small cell lung cancer patients treated with PD1 inhibitors
Presenter: Luca Cantini
Session: E-Poster Display
Resources:
Abstract
1903P - Immunotherapy for malignant pleural mesothelioma: A French retrospective real-life study
Presenter: Florian Crépin
Session: E-Poster Display
Resources:
Abstract
1904P - Clinical implications of distinct immunoprofiles in patients with thymic epithelial tumours and autoimmunity
Presenter: Giovannella Palmieri
Session: E-Poster Display
Resources:
Abstract
1905P - BAP1 and miR-31 combination predicts outcome in epithelioid malignant pleural mesothelioma
Presenter: Federica Pecci
Session: E-Poster Display
Resources:
Abstract
1906P - Lung cancer risk in solid organ transplant recipients: A meta-analysis
Presenter: Fan Ge
Session: E-Poster Display
Resources:
Abstract